Israel

Middle East

Contents

1. Regulatory Overview
2. Regulatory Pathways

Regulatory Overview

Israel is regulated by the MOH (Ministry of Health, Pharmaceutical Administration). The country has 1 documented regulatory pathway for accessing unapproved or unlicensed medicines, covering named patient programs, compassionate use schemes, and special access arrangements.

Regulatory Authority

MOH (Ministry of Health, Pharmaceutical Administration)

Regulatory Pathways (1)

Israeli MOH Compassionate Use (Section 27) – Israel 30 days

Israel allows compassionate use of unapproved drugs under Section 27 of the Pharmacists Ordinance for patients with serious or life-threatening conditions who have exhausted approved treatment options.

Application Form: MOH Israel CU Application

Legal Basis: Pharmacists Ordinance Section 27

Eligibility: Serious or life-threatening condition with no locally registered alternative

Reference: MOH Israel Section 27 Guidance

Israel

ISO Code	`IL`
Region	Middle East
Regulatory Authority	MOH (Ministry of Health, Pharmaceutical Administration)
Pathways	1 documented
Drugs Available	0 documented